Hylek EM - Search Results

1

Early adoption of dabigatran and its dosing in US patients with atrial fibrillation: results from the outcomes registry for better informed treatment of atrial fibrillation.

Steinberg BA, Holmes DN, Piccini JP, Ansell J, Chang P, Fonarow GC, Gersh B, Mahaffey KW, Kowey PR, Ezekowitz MD, Singer DE, Thomas L, Peterson ED, Hylek EM; Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Investigators and Patients. Steinberg BA, et al. Among authors: hylek em. J Am Heart Assoc. 2013 Nov 25;2(6):e000535. doi: 10.1161/JAHA.113.000535. J Am Heart Assoc. 2013. PMID: 24275632 Free PMC article.

2

Optimal oral anticoagulation for patients with nonrheumatic atrial fibrillation and recent cerebral ischemia.

Singer DE, Hylek EM. Singer DE, et al. Among authors: hylek em. N Engl J Med. 1995 Nov 30;333(22):1504. doi: 10.1056/NEJM199511303332213. N Engl J Med. 1995. PMID: 7477157 No abstract available.

3

Risk factors for intracranial hemorrhage in outpatients taking warfarin.

Hylek EM, Singer DE. Hylek EM, et al. Ann Intern Med. 1994 Jun 1;120(11):897-902. doi: 10.7326/0003-4819-120-11-199406010-00001. Ann Intern Med. 1994. PMID: 8172435

4

An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation.

Hylek EM, Skates SJ, Sheehan MA, Singer DE. Hylek EM, et al. N Engl J Med. 1996 Aug 22;335(8):540-6. doi: 10.1056/NEJM199608223350802. N Engl J Med. 1996. PMID: 8678931 Free article.

5

Acetaminophen and other risk factors for excessive warfarin anticoagulation.

Hylek EM, Heiman H, Skates SJ, Sheehan MA, Singer DE. Hylek EM, et al. JAMA. 1998 Mar 4;279(9):657-62. doi: 10.1001/jama.279.9.657. JAMA. 1998. PMID: 9496982

6

Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.

Go AS, Hylek EM, Borowsky LH, Phillips KA, Selby JV, Singer DE. Go AS, et al. Among authors: hylek em. Ann Intern Med. 1999 Dec 21;131(12):927-34. doi: 10.7326/0003-4819-131-12-199912210-00004. Ann Intern Med. 1999. PMID: 10610643

7

Prospective study of the outcomes of ambulatory patients with excessive warfarin anticoagulation.

Hylek EM, Chang YC, Skates SJ, Hughes RA, Singer DE. Hylek EM, et al. Arch Intern Med. 2000 Jun 12;160(11):1612-7. doi: 10.1001/archinte.160.11.1612. Arch Intern Med. 2000. PMID: 10847254

8

Implications of stroke risk criteria on the anticoagulation decision in nonvalvular atrial fibrillation: the Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) study.

Go AS, Hylek EM, Phillips KA, Borowsky LH, Henault LE, Chang Y, Selby JV, Singer DE. Go AS, et al. Among authors: hylek em. Circulation. 2000 Jul 4;102(1):11-3. doi: 10.1161/01.cir.102.1.11. Circulation. 2000. PMID: 10880408

9

Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.

Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, Singer DE. Go AS, et al. Among authors: hylek em. JAMA. 2001 May 9;285(18):2370-5. doi: 10.1001/jama.285.18.2370. JAMA. 2001. PMID: 11343485

10

Clinical predictors of prolonged delay in return of the international normalized ratio to within the therapeutic range after excessive anticoagulation with warfarin.

Hylek EM, Regan S, Go AS, Hughes RA, Singer DE, Skates SJ. Hylek EM, et al. Ann Intern Med. 2001 Sep 18;135(6):393-400. doi: 10.7326/0003-4819-135-6-200109180-00008. Ann Intern Med. 2001. PMID: 11560452

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

278 results

Search Page

Filters